Silver-Doped Mesoporous Bioactive Glass Nanoparticles With Core-Shell Architecture: Enhanced In Vitro Bioactivity,
Peerapat Thongnuek1, Woranop Sukparangsi2, Juntratip Jomrit3
1Biomedical Materials and Devices for Revolutionary Integrative Systems Engineering Research Unit (BMD-RISE), Biomedical Engineering Program, Biomedical Engineering Research Center, Faculty of Engineering, Chulalongkorn University, Bangkok, Thailand.
Researchers engineered novel bioactive glass nanoparticles (BGNs) with a core-shell structure. These advanced BGNs effectively release ions to combat infection and promote bone healing in orthopedic applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Regenerative Medicine
Background:
- Orthopedic biomaterials face a dual challenge: preventing infection and promoting bone regeneration.
- Bioactive glass nanoparticles (BGNs) offer potential but require precise control over ion release for optimal performance.
- Tuning silver-ion (Ag+) and calcium-ion (Ca2+) release is crucial for balancing antibacterial and osteogenic properties.
Purpose of the Study:
- To design and synthesize novel BGNs with tailored nanoarchitectures.
- To decouple and control the release of Ag+ and Ca2+ ions.
- To evaluate the antibacterial, osteogenic, and biocompatibility profiles of the engineered BGNs.
Main Methods:
- Synthesis of four BGN types using a modified sol-gel route, including solid spheres and core-shell mesoporous structures.
- Introduction of silver during synthesis and calcium impregnation for core-shell architectures.
- Characterization using electron microscopy, X-ray diffraction, energy-dispersive X-ray spectroscopy, Brunauer-Emmett-Teller analysis, and inductively coupled plasma mass spectrometry.
- In vitro evaluation of mineralization, antibacterial activity against Staphylococcus aureus and Escherichia coli, and human mesenchymal stem cell response.
- In ovo biocompatibility testing using the Hen's Egg Test on the Chorioallantoic Membrane (HET-CAM).
Main Results:
- Mesoporous BGNs exhibited significantly higher surface area (≈860 m²/g) compared to solid spheres (≈17 m²/g).
- Core-shell architectures facilitated sustained Ag+ and Ca2+ release over 21 days at low concentrations.
- Ag-doped mesoporous BGNs demonstrated potent antibacterial activity and enhanced bone mineralization.
- These BGNs supported human mesenchymal stem cell viability and osteogenic differentiation.
- No vascular irritation was observed in the HET-CAM assay, indicating good biocompatibility.
Conclusions:
- Nanostructural engineering, specifically combining mesoporosity and core-shell architectures, optimizes ion release from BGNs.
- This approach successfully balances antibacterial efficacy with osteogenic support for orthopedic applications.
- The developed multifunctional nanoglasses hold significant promise for regenerative and antimicrobial therapies.
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Microbial Corrosion
iChip


